Granules Pharmaceuticals' Chantilly site underwent a US FDA cGMP audit, yielding four Form 483 observations. No data integrity issues were reported; the company will address the procedural observations within timelines.
AI Assistant
Granules India Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.